NOA THERAPEUTICS Trademark

Trademark Overview


On Monday, February 24, 2025, a trademark application was filed for NOA THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the NOA THERAPEUTICS trademark a serial number of 99054107. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Tuesday, January 27, 2026. This trademark is owned by Noa Therapeutics. The NOA THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

pharmaceutical and veterinary preparations for the treatment of inflammatory barrier diseases, systemic inflammatory diseases, inflammatory skin diseases; cardiovascular pharmaceuticals; gastrointestinal pharmaceuticals; central nervous system pharmaceuticals; ocular and ophthalmic pharmaceuticals; nutraceuticals for the treatment of immune and inflammatory barrier diseases; medicated skin care preparations, namely, cosmeceuticals for the treatment of chronic inflammatory skin disease

Medical research in the field of immune diseases; pharmaceutical research and development
noa therapeutics

General Information


Serial Number99054107
Word MarkNOA THERAPEUTICS
Filing DateMonday, February 24, 2025
Status653 - SUSPENSION LETTER - MAILED
Status DateTuesday, January 27, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and Servicespharmaceutical and veterinary preparations for the treatment of inflammatory barrier diseases, systemic inflammatory diseases, inflammatory skin diseases; cardiovascular pharmaceuticals; gastrointestinal pharmaceuticals; central nervous system pharmaceuticals; ocular and ophthalmic pharmaceuticals; nutraceuticals for the treatment of immune and inflammatory barrier diseases; medicated skin care preparations, namely, cosmeceuticals for the treatment of chronic inflammatory skin disease
NOT AVAILABLETHERAPEUTICS
Goods and ServicesMedical research in the field of immune diseases; pharmaceutical research and development

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status CodeP - NOT AVAILABLE
Class Status DateMonday, February 24, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeP - NOT AVAILABLE
Class Status DateMonday, February 24, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNoa Therapeutics
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressToronto M5G1L7
CA

Trademark Events


Event DateEvent Description
Monday, February 24, 2025NEW APPLICATION ENTERED
Monday, February 24, 2025APPLICATION FILING RECEIPT MAILED
Wednesday, July 9, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 29, 2025ASSIGNED TO EXAMINER
Thursday, July 31, 2025NON-FINAL ACTION WRITTEN
Thursday, July 31, 2025NON-FINAL ACTION E-MAILED
Thursday, July 31, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, October 24, 2025APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Friday, October 24, 2025APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Monday, January 26, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, January 26, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 26, 2026TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 27, 2026SUSPENSION LETTER WRITTEN
Tuesday, January 27, 2026LETTER OF SUSPENSION E-MAILED
Tuesday, January 27, 2026NOTIFICATION OF LETTER OF SUSPENSION E-MAILED